Skip to main content

Coya Therapeutics, Inc.

corporate_fare Company Profile

Coya Therapeutics, Inc.

COYA·NASDAQ·Life Sciences·CIK 0001835022

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing new therapies to improve the function of regulatory T cells (Tregs). Tregs are a type of T-lymphocyte (CD4+CD25high hFOXP3+ cells) that reduce inflammation. Discovered in 1995 by Dr. Shimon Sakaguchi, who won the 2025 Nobel Prize in Physiology or Medicine, Tregs are crucial for maintaining cellular balance by regulating autoimmune and inflammatory responses and ensuring self-tolerance in mammals. Dysfunctional Tregs are linked to many diseases, often due to chronic inflammation and high oxidative stress. The severity of Treg dysfunction correlates with the progression of serious and life-threatening conditions. Coya's core focus is to develop therapies that address this Treg dysfunction, which is a key component of neurodegenerative, autoimmune, and metabolic diseases. The company has expertise in three potential therapeutic approaches: Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. These approaches include both ex vivo and in vivo methods designed to restore the suppressive and immune-modulating functions of Tregs. Coya's lead product, COYA 302, is a Treg-enhancing biologic. The company's autologous Treg cell therapy program has completed Phase 1 and Phase 2a studies for amyotrophic lateral sclerosis (ALS).

Coya Therapeutics, Inc. (NASDAQ:COYA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for COYA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for COYA spans 10-Q, 8-K, 424B5, 424B3.

Recent high-impact activity:

  • Coya Posts Wider-Than-Expected Q3 Loss, Revenue Down 93%, Going-Concern Warning
  • Coya 10-Q Flags Going Concern: $35.8M Cash, $86.4M Deficit, $10.6M Q3 Loss
  • Coya Therapeutics Completes Full Enrollment of 120 Patients in Phase 2/3 ALSTARS Trial for COYA 302 in ALS
  • Coya Therapeutics Q2 2026: $43.2M Cash, ALSTARS Enrollment on Track, Topline Data Expected Q1 2027
  • Coya Therapeutics Q2 Cash Runway Past ALS Data, Fast Track Designation Secured

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$7.95M
Net Income
-$21.23M
Diluted EPS
-$1.27
Op. Cash Flow
-$10.74M
Operating Income
-$22.56M
Cash & Equivalents
$46.82M
Debt / Equity
0.00×
Net Margin
-267.1%
Shares Outstanding
20.93M sh
Source: 10-K · filed 2026-03-16 · accession 0001193125-26-107281

Short Interest & Short Volume

11.89 days to cover

FINRA reported short interest of 1,410,974 shares in COYA as of the October 30, 2026 settlement, a 12.4% increase from the prior period — about 11.9 days to cover at its recent average daily volume. On November 20, 2026, 39.6% of COYA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,410,974 shares as of October 30, 2026
Change vs prior period▲ 12.4%
Days to cover11.89 at avg daily volume of 118,633
Daily short volume (FINRA facilities)39.6% of 83,564 shares on November 20, 2026
5-day average short volume35.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$2.95
52-week range · as of 2026-11-10 $2.72 – $6.62
Market cap
$69.2M
Volume
138.3K (0.8× avg)
3-mo avg 169.3K
Live data · 2026-11-21 22:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COYA - Latest Insights

COYA
Nov 10, 2026, 9:32 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $2.95 info
Change: -$0.310 (-10%) info
Market Cap: $69.201M info
COYA
Nov 10, 2026, 8:09 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.26
Real-time Price: $2.95 info
Change: -$0.310 (-10%) info
Market Cap: $69.201M info
COYA
Oct 05, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.06
Real-time Price: $2.95 info
Change: -$2.11 (-42%) info
Market Cap: $69.201M info
COYA
Aug 11, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.62
Real-time Price: $2.95 info
Change: -$1.67 (-36%) info
Market Cap: $69.201M info
COYA
Aug 11, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.83
Real-time Price: $2.95 info
Change: -$1.88 (-39%) info
Market Cap: $69.201M info
COYA
May 12, 2026, 8:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.22
Real-time Price: $2.95 info
Change: -$1.27 (-30%) info
Market Cap: $69.201M info
COYA
May 12, 2026, 8:44 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $4.22
Real-time Price: $2.95 info
Change: -$1.27 (-30%) info
Market Cap: $69.201M info
COYA
May 12, 2026, 7:41 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.35
Real-time Price: $2.95 info
Change: -$1.40 (-32%) info
Market Cap: $69.201M info
COYA
May 12, 2026, 7:39 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $2.95 info
Change: -$1.45 (-33%) info
Market Cap: $69.201M info
COYA
May 12, 2026, 7:35 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.63
Real-time Price: $2.95 info
Change: -$1.68 (-36%) info
Market Cap: $69.201M info
COYA
Mar 20, 2026, 4:30 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.21
Real-time Price: $2.95 info
Change: -$1.26 (-30%) info
Market Cap: $69.201M info
COYA
Mar 16, 2026, 9:20 AM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $4.55
Real-time Price: $2.95 info
Change: -$1.60 (-35%) info
Market Cap: $69.201M info
COYA
Mar 16, 2026, 8:11 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $4.51
Real-time Price: $2.95 info
Change: -$1.56 (-35%) info
Market Cap: $69.201M info
COYA
Mar 16, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.51
Real-time Price: $2.95 info
Change: -$1.56 (-35%) info
Market Cap: $69.201M info
COYA
Jan 30, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.75
Real-time Price: $2.95 info
Change: -$1.80 (-38%) info
Market Cap: $69.201M info
COYA
Jan 20, 2026, 8:20 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.40
Real-time Price: $2.95 info
Change: -$1.45 (-33%) info
Market Cap: $69.201M info
COYA
Jan 08, 2026, 8:10 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.29
Real-time Price: $2.95 info
Change: -$2.34 (-44%) info
Market Cap: $69.201M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets